本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rocket Pharmaceuticals, Inc.

2.96
-0.1500-4.82%
盘后2.990.0300+1.01%19:29 EDT
成交量:211.18万
成交额:640.62万
市值:3.23亿
市盈率:-1.58
高:3.17
开:3.09
低:2.93
收:3.11
52周最高:6.43
52周最低:2.19
股本:1.09亿
流通股本:7,878.63万
量比:0.78
换手率:2.68%
股息:- -
股息率:- -
每股收益(TTM):-1.8756
每股收益(LYR):-2.0100
净资产收益率:-64.41%
总资产收益率:-35.14%
市净率:1.36
市盈率(LYR):-1.47

数据加载中...

2025/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/15

重要事件披露

Form 8-K - Current report
2025/05/08

重要事件披露

Form 8-K - Current report
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/07

重要事件披露

Form 8-K - Current report
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities